Prospective Multi-Center Trial for FemBloc Permanent Birth Control

ConditionContraception
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-50
SponsorFemasys Inc.

About this trial

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female, 21 - 50 years of age desiring permanent birth control.

Sexually active with male partner.

Regular menstrual cycle for last 3 months or on hormonal contraceptives.

Disqualifiers

Uncertainty about the desire to end fertility.

Known or suspected pregnancy.

Prior tubal surgery, including sterilization attempt.

Presence, suspicion, or previous history of gynecologic malignancy.

Trial design

Design model

Single group

Treatments tested in this trial

  • FemBloc

    Device

    Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.

Treatment groups

573 Participants
are divided into 1 treatment group
Group A: FemBlocExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pregnancy Rate

Number of subjects who were told to rely on FemBloc for birth control and became pregnant through one (1) year.

Time frame
one (1) year

Secondary outcomes

1

Reliance Rate

Number of subjects who were told to rely on FemBloc.

Time frame
ninety (90) days post treatment
2

Long term Pregnancy Rate

Number of subjects who were told to rely on FemBloc for birth control that became pregnant after one (1) year through 2-, 3-, 4-, and 5-years.

Time frame
Five (5) years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.